6:25 PM
 | 
Jan 23, 2013
 |  BC Extra  |  Top Story

Vasella to step down as Novartis chair

Novartis AG (NYSE:NVS; SIX:NOVN) disclosed in its 4Q12 earnings that Chairman Daniel Vasella decided not to stand for reelection at the pharma's annual general meeting on Feb. 22. Vasella, who was CEO during 1996-2010, has been chairman since 1999. The pharma's board expects Joerg Reinhardt to become chairman, effective Aug. 1. Reinhardt, who was COO at Novartis during 2008-10, is slated for...

Read the full 295 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >